He, S., Liu, T., Zhang, Y. (2025). ADRB2-driven immunosuppression as a novel prognostic indicator and therapeutic avenue following neoadjuvant treatment in colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15533